Scientists hunt for a 'Crystal Ball' to personalize skin cancer treatment
NCT ID NCT07436390
Summary
This study aimed to find a better way to predict which patients with advanced skin cancer (metastatic melanoma) would respond well to a common type of immunotherapy. Researchers measured levels of a protein called interferon-gamma in patients' tumors and blood, and also looked at their gut bacteria, to see if these factors were linked to treatment success. The goal was to help doctors personalize treatment by identifying patients most likely to benefit from these powerful drugs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institute of Oncology Ljubljana
Ljubljana, 1000, Slovenia
Conditions
Explore the condition pages connected to this study.